genetikode.com

What It Is

Genetikode positions itself as a precision oncology genomics and epigenomics company. Its core offering combines DNA, RNA, and methylation testing with AI-native bioinformatics software for early cancer detection, treatment-related biomarker discovery, MRD monitoring, and clinical-grade interpretation reports. Its products include testing services for tissue samples, liquid biopsy, hematologic malignancies, and hereditary risk, as well as the unified PrecisionAI analytics software.

Core Capabilities

Based on the information on its website, PrecisionAI supports WGS, WES, Panel, RNA-seq, and methylation analysis. It can ingest FASTQ, BAM/CRAM, and methylation matrices, and provides AI-driven prioritization of variants and genomic events, annotation, QC checkpoints, evidence mapping, and ACMG-aligned classification. The outputs appear to be “report-ready,” making it suitable for molecular diagnostics teams looking to reduce manual review workload. However, the site does not disclose model architecture, training data, clinical validation metrics, sensitivity/specificity, or regulatory certifications, so its AI capabilities still need to be confirmed through sample validation and third-party evaluation.

Pricing and Integration

The website does not disclose pricing, licensing models, free trials, or testing service quotes; it only provides email and phone contact options. In terms of integration, it clearly supports multiple genomic data formats and customizable exports to downstream reporting systems, but does not specify API, SDK, LIMS/EHR integration capabilities, or deployment options. Hospitals and laboratories considering procurement should still ask about on-premise deployment, cloud processing, data retention, audit trails, and compliance terms.

Pros and Cons

Its strengths are broad multi-omics coverage and a product line spanning tissue testing, liquid biopsy, MRD, hematologic malignancies, and germline risk, while bringing analysis, interpretation, and reporting into a unified workflow. The main weakness is limited disclosure of key information, especially pricing, privacy and security, clinical validation, Chinese-language support, and cross-border service capabilities. Its “AI” appears to function more as workflow enhancement and prioritization rather than as an independently validated diagnostic model with publicly demonstrated performance.

Who It’s For and Access from China

Genetikode is better suited for molecular diagnostics laboratories, oncology centers, and translational medicine teams evaluating partnerships or software adoption. Access from China, payment options, and Chinese-language service availability are unknown. If samples or genomic data are transferred across borders, compliance should be reviewed carefully. Domestic alternatives may include Burning Rock Biotech, Genetron Health, and BGI-affiliated oncology testing and bioinformatics platforms, while international alternatives include Illumina DRAGEN, Sophia Genetics, Fabric Genomics, and DNAnexus.